Leigh Ellis
Prostate Cancer Research(GB)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Cancer, Lipids, and Metabolism, Cancer, Hypoxia, and Metabolism, Diet and metabolism studies, Advanced Breast Cancer Therapies
Most-Cited Works
- → Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance(2017)1,074 cited
- → SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 - and RB1 -deficient prostate cancer(2017)1,023 cited
- → Epigenetics in cancer: Targeting chromatin modifications(2009)488 cited
- MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.(1997)
- → Histone Deacetylase Inhibitor Panobinostat Induces Clinical Responses with Associated Alterations in Gene Expression Profiles in Cutaneous T-Cell Lymphoma(2008)299 cited
- → Prostate cancer reactivates developmental epigenomic programs during metastatic progression(2020)280 cited
- → Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer(2018)277 cited
- → ONECUT2 is a driver of neuroendocrine prostate cancer(2019)239 cited
- → EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer(2021)232 cited
- → Targeting tumor angiogenesis with histone deacetylase inhibitors(2008)232 cited